Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 11/2010

01-11-2010 | Retinal Disorders

Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 ml bevacizumab: comparison between 27-gauge and 30-gauge needle

Authors: Katrin Lorenz, Isabella Zwiener, Alireza Mirshahi

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 11/2010

Login to get access

Abstract

Purpose

Intravitreal injections may lead to a significant elevation of the intraocular pressure (IOP). A paracentesis may become necessary for acute reduction of the IOP in certain cases. The purpose of this study was to determine the frequency of paracentesis performed and the grade of reflux under the conjunctiva after injection of 0.1 ml bevacizumab (1.25 mg), depending on the thickness of the needles used.

Methods

A retrospective review was undertaken of the surgery reports of 234 consecutive intravitreal bevacizumab injections in 145 eyes of 144 patients within 14 months. In particular, the frequency of paracentesis, the thickness of the needles used (27-gauge versus 30-gauge), the lens status, and a semi-quantitative reflux grade were analysed.

Results

A paracentesis was performed in 78 cases (33%) for acute reduction of the IOP. In the 27-gauge group the frequency was 26% (25 of 96), and in the 30-gauge group 38% (53 of 138) (p = 0.05, independent estimating equation (IEE)). The medians of the semi-quantitative assessment of the reflux grade under the conjunctiva were 2.0 in the 27-gauge group (corresponding to a mild reflux) and 1.0 in the 30-gauge group (corresponding to a minimal reflux, p < 0.001, IEE).

Conclusions

When using a 30-gauge needle for intravitreal injections, the reflux under the conjunctiva was less than with a 27-gauge needle. However, the use of a 30-gauge needle appeared to be associated with a higher frequency of paracentesis.
Literature
1.
go back to reference Rodrigues EB, Meyer CH, Schmidt JC, Hoerle S, Kroll P (2004) Unsealed sclerotomy after intravitreal injection with a 30-gauge needle. Retina 24:810–812CrossRefPubMed Rodrigues EB, Meyer CH, Schmidt JC, Hoerle S, Kroll P (2004) Unsealed sclerotomy after intravitreal injection with a 30-gauge needle. Retina 24:810–812CrossRefPubMed
2.
go back to reference Jager RD, Aiello LP, Patel SC, Cunningham ET Jr (2004) Risks of intravitreous injection: a comprehensive review. Retina 24:676–698CrossRefPubMed Jager RD, Aiello LP, Patel SC, Cunningham ET Jr (2004) Risks of intravitreous injection: a comprehensive review. Retina 24:676–698CrossRefPubMed
3.
go back to reference Bakri SJ, Pulido JS, McCannel CA, Hodge DO, Diehl N, Hillemeier J (2009) Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye 23:181–185CrossRefPubMed Bakri SJ, Pulido JS, McCannel CA, Hodge DO, Diehl N, Hillemeier J (2009) Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye 23:181–185CrossRefPubMed
4.
go back to reference Benz MS, Albini TA, Holz ER, Lakhanpal RR, Westfall AC, Iyer MN, Carvounis PE (2006) Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology 113:1174–1178CrossRefPubMed Benz MS, Albini TA, Holz ER, Lakhanpal RR, Westfall AC, Iyer MN, Carvounis PE (2006) Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology 113:1174–1178CrossRefPubMed
5.
go back to reference Morlet N, Young SH (1993) Prevention of intraocular pressure rise following intravitreal injection. Br J Ophthalmol 77:572–573CrossRefPubMed Morlet N, Young SH (1993) Prevention of intraocular pressure rise following intravitreal injection. Br J Ophthalmol 77:572–573CrossRefPubMed
6.
go back to reference Rodrigues EB, Meyer CH, Grumann A Jr, Shiroma H, Aguni JS, Farah ME (2007) Tunneled scleral incision to prevent vitreal reflux after intravitreal injection. Am J Ophthalmol 143:1035–1037CrossRefPubMed Rodrigues EB, Meyer CH, Grumann A Jr, Shiroma H, Aguni JS, Farah ME (2007) Tunneled scleral incision to prevent vitreal reflux after intravitreal injection. Am J Ophthalmol 143:1035–1037CrossRefPubMed
7.
go back to reference Ziemssen F, Heiduschka P, Peters S, Grisanti S, Schraermeyer U (2008) Chances and risks of anti-VEGF therapy. Klin Monatsbl Augenheilkd 225:770–778CrossRefPubMed Ziemssen F, Heiduschka P, Peters S, Grisanti S, Schraermeyer U (2008) Chances and risks of anti-VEGF therapy. Klin Monatsbl Augenheilkd 225:770–778CrossRefPubMed
8.
go back to reference Modarres M, Nazari H, Falavarjani KG, Naseripour M, Hashemi M, Parvaresh MM (2009) Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol 19:848–852PubMed Modarres M, Nazari H, Falavarjani KG, Naseripour M, Hashemi M, Parvaresh MM (2009) Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol 19:848–852PubMed
9.
go back to reference Kotliar K, Maier M, Bauer S, Feucht N, Lohmann C, Lanzl I (2007) Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomechanical model. Acta Ophthalmol Scand 85:777–781CrossRefPubMed Kotliar K, Maier M, Bauer S, Feucht N, Lohmann C, Lanzl I (2007) Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomechanical model. Acta Ophthalmol Scand 85:777–781CrossRefPubMed
10.
go back to reference Boon CJ, Crama N, Klevering BJ, van Kuijk FJ, Hoyng CB (2008) Reflux after intravitreal injection of bevacizumab. Ophthalmology 115:1270, author reply 1271CrossRefPubMed Boon CJ, Crama N, Klevering BJ, van Kuijk FJ, Hoyng CB (2008) Reflux after intravitreal injection of bevacizumab. Ophthalmology 115:1270, author reply 1271CrossRefPubMed
11.
go back to reference Huang WC, Lin JM, Chiang CC, Tsai YY (2008) Necessity of paracentesis before or after intravitreal injection of bevacizumab. Arch Ophthalmol 126:1314–1315, author reply 1315CrossRefPubMed Huang WC, Lin JM, Chiang CC, Tsai YY (2008) Necessity of paracentesis before or after intravitreal injection of bevacizumab. Arch Ophthalmol 126:1314–1315, author reply 1315CrossRefPubMed
12.
go back to reference He Z, Bui BV, Vingrys AJ (2008) Effect of repeated IOP challenge on rat retinal function. Invest Ophthalmol Vis Sci 49:3026–3034CrossRefPubMed He Z, Bui BV, Vingrys AJ (2008) Effect of repeated IOP challenge on rat retinal function. Invest Ophthalmol Vis Sci 49:3026–3034CrossRefPubMed
13.
go back to reference He Z, Bui BV, Vingrys AJ (2006) The rate of functional recovery from acute IOP elevation. Invest Ophthalmol Vis Sci 47:4872–4880CrossRefPubMed He Z, Bui BV, Vingrys AJ (2006) The rate of functional recovery from acute IOP elevation. Invest Ophthalmol Vis Sci 47:4872–4880CrossRefPubMed
14.
go back to reference Sharei V, Höhn F, Köhler T, Hattenbach LO, Mirshahi A (2010) Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis®). Eur J Ophthalmol 20:174–179PubMed Sharei V, Höhn F, Köhler T, Hattenbach LO, Mirshahi A (2010) Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis®). Eur J Ophthalmol 20:174–179PubMed
15.
go back to reference Raju JR, Weinberg DV (2002) Accuracy and precision of intraocular injection volume. Am J Ophthalmol 133:564–566CrossRefPubMed Raju JR, Weinberg DV (2002) Accuracy and precision of intraocular injection volume. Am J Ophthalmol 133:564–566CrossRefPubMed
Metadata
Title
Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 ml bevacizumab: comparison between 27-gauge and 30-gauge needle
Authors
Katrin Lorenz
Isabella Zwiener
Alireza Mirshahi
Publication date
01-11-2010
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 11/2010
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-010-1490-y

Other articles of this Issue 11/2010

Graefe's Archive for Clinical and Experimental Ophthalmology 11/2010 Go to the issue